Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil for recurrent idiopathic nephrotic syndrome in children
IRCT20130812014333N113Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of mycophenolate mofetil in Idiopathic nephrotic syndrome (INS) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Digestive complications, Infection and 1 more. Started Mar 2019; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Idiopathic nephrotic syndrome (INS)
Beyond the preview
Go deeper on IRCT20130812014333N113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N113.